103 Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?

article

106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie

113 Cone beam computed tomography (CBCT) based adaptive radiotherapy for lung cancer? The Christie experience

113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?

article

118 Smoking habits in lung cancer patients and their carers and audit of smoking advice given

article

1260POUTCOMES OF ELDERLY PATIENTS (≥70 YO) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A MULTI-INSTITUTIONAL ANALYSIS

article

1282PBRAIN METASTASES (BM) IN PATIENTS WITH EGFR MUTATIONS – A REVIEW OF INCIDENCE AND OUTCOMES

article

136 Electronic patient reported outcomes significantly improved toxicity data collection and were acceptable to both patients and clinicians in lung cancer radiotherapy outpatient clinics

article

144: A single centre's experience of toxicity, compliance and survival in patients with stage III locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemo-radiotherapy (CCTRT)

article

146 One year on: early report of intensity modulated radiotherapy (IMRT) for locally advanced lung cancer at the Christie

150 Ninety-day mortality following radical radiotherapy for lung cancer

150: A re-audit of mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centre

152 The impact of IMRT on the treatment of patients with N3M0 lung cancer at The Christie

154 Concurrent chemoradiotherapy (cCTRT) for locally-advanced, unresectable non-small cell lung cancer (LA-NSCLC): A national survey of current practice

155: Predictors of failure for PS2–3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC – experience of a UK centre

156: Outcome for performance status 2–3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC

157 Comparison of outcomes for early small cell lung cancer (SCLC) treated with surgery versus concurrent chemo radiation (CTRT)

article

157 Mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centre

157 Radical radiotherapy for NSCLC in the very elderly: Can failure to tolerate treatment be predicted?

160 The largest single centre series using hypofractionated radical radiotherapy treatment for NSCLC (non-small cell lung cancer) in the very elderly

161 Acute toxicity of prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ES-SCLC): A prospective audit from a UK radiotherapy centre

article

161 Investigation of a patient reported outcome tool to assess radiotherapy-related toxicity in patients with lung cancer

article

162 Intensity modulated radiotherapy (IMRT) in locally advanced non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): Analysis of survival and toxicity outcomes

article

163 REST: A randomised trial comparing prophylactic cranial irradiation (PCI) to PCI + thoracic radiotherapy in extensive stage small cell lung cancer (ES-SCLC)

164 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced oesophageal toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)

article

165 An investigation into the efficacy and toxicity of stereotactic ablative body radiotherapy for lung cancer at The Christie NHS Foundation Trust

article

165 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced pulmonary toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)

article

166 Audit on the characteristics of lung cancer patients who receive BSC (best supportive care)

article

167: Thoracic radiotherapy in extensive stage small cell lung cancer

article

173 Assessing CT changes post stereotactic ablative body radiotherapy (SABR) using the criteria proposed by Senan et al

183: PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

184 Toxicities and compliance to treatment in locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemoradiotherapy (cCTRT) at the Christie NHS Foundation Trust

article

193 PIT: a phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

216 PIT: A phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

31 The use of pemetrexed in advanced non-small cell lung cancer

article

48 Radical management of inoperable stage III non-small cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN) – an analysis of patient eligibility and justification for treatment

69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention

78P AVAILABILITY OF EGFR MUTATION STATUS AT FIRST ONCOLOGY CONSULTATION FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS. A PILOT EXPERIENCE FROM THE CHRISTIE

article

89 Management of stage III non-small-cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN): an analysis of current practice

97 PIT: A Phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

98 A paradigm shift IMRT enables radical treatment in locally advanced lung cancer patients who would have been treated with palliative intent with 3D conformal radiotherapy (3D CRT)

A re-audit of patient selection and mortality rates after palliative radiotherapy (PRT) in patients with non-small cell lung cancer (NSCLC)

An Examination of the Recruitment of Patients to NCRN (National Cancer Research Network) Lung Cancer Radiotherapy Trials at The Christie

An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases to QUARTZ and TACTIC clinical trials in a UK cancer centre

Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.

artículo científico publicado en 2013

Concurrent Chemoradiotherapy for Locally Advanced, Unresectable Non-small Cell Lung Cancer: A UK Survey of Current Practice

artículo científico publicado en 2012

Do we need another randomised controlled trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention?

EP-1527: Early results from a clinical trial of visual feedback from dynamic optical surface sensing in lung cancer patients

scholarly article by G. Price et al published April 2015 in Radiotherapy and Oncology

Early Report of Intensity Modulated Radiotherapy (IMRT) for Locally Advanced Lung Cancer at The Christie

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?

artículo científico

Impact of Integration of Fused FDG-PET and CT Information for GTV Delineation

Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer

artículo científico publicado en 2014

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment

artículo científico publicado en 2008

Multidisciplinary Team Service Redesign: a Step to Improved Quality of Care for Lung Cancer Patients

artículo científico publicado en 2016

New radiotherapy approaches in locally advanced non-small cell lung cancer

artículo científico

Optimising recruitment rates to radiotherapy clinical trials for patients with non-small cell lung cancer and brain metastases

artículo científico publicado en 2010

PO-0663: Lung V5 does not predict for lung toxicity after fixed-beam intensity modulated radiotherapy (IMRT) for lung cancer

article

PO-0688: Concurrent CTRT (cCTRT) for locally advanced NSCLC followed by consolidation pemetrexed: a phase II study

scholarly article by Corinne Faivre-Finn et al published 2014 in Radiotherapy and Oncology

PO-0744 IS 14 DAY MORTALITY A USEFUL MEASURE OF PALLIATIVE RADIOTHERAPY EFFICACY IN LUNG CANCER

scholarly article by K. Gupta et al published May 2012 in Radiotherapy and Oncology

PO-0988: Evaluation of set up margins and a correction protocol in radical radiotherapy for lung cancer

scholarly article by L. Minchell et al published 2014 in Radiotherapy and Oncology

Primary radiotherapy for carcinoma of the retromolar trigone: a useful alternative to surgery

artículo científico publicado en 2009

Prise en charge du cancer bronchique à petites cellules (CPC) (localisé et étendu)

Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice

artículo científico publicado en 2009

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

artículo científico publicado en 2016

Radiotherapy for lung cancer in the elderly

scientific article published on 15 January 2010

Radiotherapy for small-cell lung cancer-Where are we heading?

artículo científico publicado en 2008

Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice

Reactive Plan Adaptation for Lung Radiotherapy Based on Cone Beam CT —The Christie Experience

The impact of lymphovascular invasion on survival in oral carcinoma

artículo científico publicado en 2008

The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderly

artículo científico publicado en 2013